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Background: Hyperadrenocorticism (HAC) is associated with an increased prevalence of hypertension. This study
investigated the left ventricular function using two-dimensional speckle-tracking echocardiography (2D-STE) in small
breed dogs affected with spontaneous HAC.
Age-matched healthy controls (n = 9), dogs with pituitary-dependent hyperadrenocorticism (PDH, n = 10), and
dogs with adrenal-dependent hyperadrenocorticism (ADH, n = 9) were included in this study. Conventional
echocardiography, global longitudinal and circumferential strain, and strain rate were assessed.
Results: On group-wise comparison, left ventricular free wall (LVFWd) and interventricular septal thickness in
diastole (IVSd) were thickest in the ADH group, followed by the PDH and controls (P = 0.014 and P = 0.001, respectively).
Neither LVFWd nor IVSd was correlated with systemic blood pressure (P = 0.238 and P = 0.113, respectively). The
values of all variables derived from the global strain and strain rate in longitudinal and circumferential directions
followed the same pattern: highest in the controls, followed by PDH and then ADH (all P < 0.05, respectively). On
multiple regression analyses, global longitudinal strain, global longitudinal strain rate in systole and early diastole,
and global circumferential strain all decreased linearly with increased IVSd (all P < 0.05).
Conclusions: Left ventricular hypertrophy (LVH) was more prevalent in the HAC group compared to the control
group. Association between hypertension and development of LVH was not identified. Decreased global
longitudinal and circumferential strains were associated with increased IVSd. 2D-STE revealed significant decreases
in systolic functions that were undetected using conventional echocardiography in the ADH and PDH groups.
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Hyperadrenocorticism (HAC) is a condition of chronic-
ally elevated circulating glucocorticoid concentration. In
response to stimulation of the renin-angiotensin system
and mineralocorticoid and glucocorticoid receptors of
myocytes, development of systemic hypertension, left ven-
tricular hypertrophy (LVH), and myocardial fibrosis are
commonly observed in human patients with HAC [1-3].
The left ventricular wall thickness is significantly increased
in HAC patients with concomitant hypertension compared
with non-HAC hypertensive controls. Increased ventricular* Correspondence: hphuang@ntu.edu.tw
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unless otherwise stated.wall thickness is also detected in normotensive patients with
HAC compared with age-, sex- and body mass index-
matched controls [4]. Active HAC increases risk of myo-
cardial fibrosis compared to both normal subjects and
hypertensive patients with similar left ventricular wall thick-
ness and mass index [5]. These findings indicate that hyper-
cortisolism exacerbates changes in ventricular mass.
Human patients with HAC and concomitant hyperten-
sion have a two-fold greater risk of detection of cardiac
mass abnormality compared with normotensive patients
and hypertensive controls [4]. Hypertension may also lead
to LVH, which is characterized by concentric remodeling
[6-8]. Systemic hypertension is also commonly observed
in dogs with HAC [9,10]. However, studies of cardiac dis-
ease in dogs with HAC are relatively limited. Hypertrophic
cardiomyopathy or LVH is not commonly observed inhis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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[11]. The aims of the study were to report the preva-
lence of LVH and to assess the left ventricular systolic
and diastolic function using two-dimensional speckle-




Age-matched healthy controls (controls)
Client-owned dogs visiting the National Taiwan University
Veterinary Hospital (NTUVH) during 2010 and 2012 for
routine wellness checkups were included in this study.
Thorough medical histories were obtained, and physical
examinations, routine blood analyses (complete blood
counts and biochemical profiles), chest radiographic ex-
aminations, abdominal ultrasonographic examinations,
echocardiographic examinations (two-dimensional (2D),
M-mode, and Doppler) and 2D-STE were performed to
exclude the presence of any forms of systemic, cardiac,
renal, and adrenal disease. Nine dogs (five males and
four females) were deemed clinically healthy and cate-
gorized as age-matched healthy controls (controls).
Dogs with hyperadrenocorticism (HAC group)
Client-owned dogs affected with HAC during the same
period of time were included in this group. Inclusion cri-
teria of HAC included evidence of clinical signs consist-
ent with a diagnosis of HAC (e.g., polydipsia, polyuria,
polyphagia, decreased activity, panting, a potbellied ap-
pearance, and dermatologic problems), results of routine
serum biochemical analyses consistent with a diagnosis
of HAC (i.e., elevated activities of hepatic enzymes), and
results of ACTH stimulation tests consistent with a
diagnosis of HAC. Dogs with inconclusive results from
ACTH stimulation tests were excluded from the study.
All included dogs with HAC were required to have re-
ceived an ACTH stimulation test with intramuscular
injection of 0.25 mg of synthetic ACTH (Cortrosyn;
Organon, the Netherlands) prior to treatment. Blood sam-
ples for the detection of serum cortisol concentrations
were collected via cephalic venipuncture immediately
before and one hour after synthetic ACTH was injected
[12]. Serum cortisol concentrations were measured by use
of a validated radioimmunoassay (Coat-A-Count Cortisol;
Diagnostic Products Corp., Los Angeles, California). Fur-
ther differentiation between PDH and ADH was based
upon adrenal ultrasonographic assessment [13,14]. Nor-
mal or mildly and bilaterally enlarged adrenal glands
were classified as PDH, whereas ultrasonographic find-
ings of adrenals with asymmetry, abnormal enlarge-
ment, or irregular or round shape, or nodules/masses
identified in the entire adrenal or in one pole - with
heterogenicity and mineralized foci - were diagnosed asADH [13,14]. Equivocal cases and cases that presented
with bilaterally and irregularly enlarged/round adrenals
were excluded from the study.
Systolic blood pressure measurement
Systolic blood pressure was measured using the indirect
method of Doppler flow detection with a 9.5 MHz trans-
ducer. A Doppler Ultrasonic Flow Detector (Model 811-B,
Parks Medical Electronics Inc., U.S.A.) with an inflatable
cuff width of 1.9 or 2.5 cm (approximately 40% of the cir-
cumference of the antebrachium) was used. During sys-
temic blood pressure measurement, the antebrachium was
maintained at the level of the heart. A series of five readings
(with 10 to 20 seconds between consecutive measurements)
was obtained for each dog. To minimize procedural stress,
all dogs were allowed to assume a comfortable position
with only gentle restraint by their owners. The dogs
remained in the same position throughout systemic
blood pressure measurement. The final systemic blood
pressure value was calculated as the mean of five readings.
The heart rate was manually recorded by pulse Doppler
ultrasound detection over a period of 20 seconds after the
systemic blood pressure value was measured. Dogs were
considered to be hypertensive if the average systemic
blood pressure exceeded 160 mm Hg [15].
Conventional echocardiography
Conventional echocardiography was performed without
sedation in gently restrained recumbent positions. Stand-
ard echocardiographic views were obtained in right and
left lateral recumbency using the 2D-guided M mode with
ultrasound units equipped with 2–5 and 5–7.5 MHz
transducers (MyLab™ 50 Family, Esaote, Genova, Italy).
Measurements of left ventricular end-diastolic diameter
(LVEDD), left ventricular end-systolic diameter (LVESD),
left ventricular free-wall thickness (LVFWd) and interven-
tricular septal thickness (IVSd) at end-diastole, ejection
fraction (EF), and fractional shortening (FS) were obtained
from the right parasternal long-axis view. The left atrium
to aorta ratio (LA/AO) was measured in the right para-
sternal short-axis view. Values for the inflow of the max-
imal early (E) and late (A) diastolic mitral and tricuspid
flow velocities, E/A ratio, and isovolumic relaxation time
(IVRT) were determined by pulsed-wave Doppler from
the left apical four- or five-chamber view.
Inclusion criteria of left ventricular hypertrophy
Inclusion of LVH was based on conventional echocardio-
graphic examinations. LVH was defined as regional or
generalized concentric hypertrophy with a diastolic wall
thickness ≧ 7 mm of the LVFWd or ≧ 6 mm of the IVSd
in dogs with a body weight of < 5 kg, and with a diastolic
wall thickness of ≧ 8 mm of the LVFWd or ≧ 7 mm of the
IVSd in dogs with a body weight of 5–11 kg [16].
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2D-STE examinations were performed at the end of con-
ventional echocardiography for all dogs. The standard
left apical long-axis four-chamber and the right paraster-
nal short-axis views at the level of papillary muscles were
obtained using a frame rate above 60 per second. For
each dog, three consecutive cardiac cycles were recorded
using one single loop, and digitally stored in a hard disk
for offline analysis on a workstation (XStrain™ software
for MyLab™ 50 XVision, Esaote, Genova, Italy). The 2D-
STE variables included strain, and strain rate. Circumfer-
ential strain rate in peak systole (CSRS), circumferential
strain rate in early diastole (CSRE), circumferential strain
rate in late diastole (CSRA) and peak circumferential
strain (CS) were measured from the right parasternal
short-axis view at the level of the papillary muscles. The
software automatically divided the left ventricle into six
segments based on standard segmentation model used
in human patients [17] (Figure 1). Longitudinal strain
rate in peak systole (LSRS), longitudinal strain rate in early
diastole (LSRE), longitudinal strain rate in late diastole
(LSRA), and peak longitudinal strain (LS) were measured
from the left apical long-axis four-chamber view. The soft-
ware automatically divided into three segments in each
the left ventricular free wall and interventricular septum
based on standard segmentation model used in human pa-
tients [18] (Figure 2). Only images with > 4/6 segments ofFigure 1 Two-dimensional speckle-tracking echocardiography analysi
male Maltese terrier, 4.0 kg) with pituitary-dependent hyperadrenoco
six segments in the short axis view: middle anterior septal wall (MIDANTSEP
ventricular wall (MID LAT), middle posterior left ventricular wall (MID POST)
septum (MID SEP).adequate tracking quality were included for analysis. Glo-
bal strain and strain rate were calculated by averaging the
values of all segmental circumferential/longitudinal strain
and strain rate.Statistical analysis
Data are presented as mean ± standard deviation (SD).
Descriptive statistical analyses were performed with a
with commercial computer statistics software (Statistical
Product and Service Solutions (SPSS) Version 12.0.1, SPSS
Inc. in Chicago, IL, USA.). Continuous data were tested
for normality by use of the D’Agostino-Pearson omnibus
test and Shapiro-Wilk test. All tests were two-tailed, and a
P value < 0.05 was considered statistically significant. Nor-
mal distribution was found in all continuous data includ-
ing, variables derived from conventional echocardiography
and STE.
Overall group-wise in continuous data (age, heart rate,
systemic blood pressure, body weight), as well as con-
ventional echocardiographic and STE-derived variables,
among the PDH, ADH, and control groups were investi-
gated using analysis of variance and post hoc tests with
a Scheffe-adjusted P value for multiple comparisons.
The relationships between STE-derived variables and age,
systemic blood pressure, body weight, LVFWd, and IVSd
were assessed using Pearson’s correlation coefficient.s of left ventricular circumferential strain in a dog (15 years old
rticism. The left ventricular myocardium is automatically divided into
), middle anterior left ventricular wall (MID ANT), middle lateral left
, middle inferior left ventricular wall (MID INF), middle ventricular
Figure 2 Two-dimensional speckle-tracking echocardiography analysis of left ventricular longitudinal strain in a dog (10 years old male
Maltese terrier, 3.2 kg) with pituitary-dependent hyperadrenocorticism. The left ventricular myocardium is automatically divided into six
segments: basal (BAS SEP), middle (MID SEP) and apical (APIC SEP) segments for the interventricular septum, and basal (BAS LAT), middle (MID
LAT) and apical (APIC LAT) lateral segments for the left ventricular free wall.
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performed with the measured STE-derived variables as
dependent variables and the independent variables of gen-
der, age, heart rate, systemic blood pressure, IVSd, and
LVFWd. A Chi-square test was used to assess differences
in categorical variables among the groups. Comparison of
the systemic blood pressure, conventional echocardio-
graphic variables, and 2D-STE derived variables between
LVH dogs and controls was performed using Student’s un-
paired two-tailed t tests.
The intra-observer coefficients of variations (CV) of
the conventional echocardiographic and 2D-STE derived
variables were calculated by a variance component ana-
lysis. The CV was determined by dividing the SD value by
the overall mean. Six clinically healthy dogs were scanned
on three nonconsecutive occasions within one day by the
same examiner (HYC), who was unaware of values from
the initial examination.
Results
Baseline descriptions of the animals
The breeds represented in the controls included one mini-
ature dachshund and two each of Maltese terriers, mini-
ature Schnauzers, mixed breeds, and Yorkshire terriers.
The mean age of the control was 10.5 ± 2.8 years (range: 7
to 15 years) and the mean body weight was 6.2 ± 2.7 kg
(range: 2.6 to 10.0 kg). Nineteen dogs with HAC were
included: 10 dogs with pituitary-dependent hyperadreno-
corticism (PDH) and nine dogs with adrenal-dependenthyperadrenocorticism (ADH). The breed distribution of
the 19 dogs with HAC was as follows: eight Maltese ter-
riers, five Shih-Tzus, and one each of Chihuahua, miniature
Schnauzer, Pomeranian, toy poodle, short-haired dachs-
hund, and Yorkshire terrier. The mean age of the 10 dogs
(five males and five females) with PDH was 12.5 ± 2.0 years
(range: 9 to 15 years) and the mean body weight of this
groups was 4.5 ± 1.4 kg (range: 3.2 to 6.6 kg). The mean
age of the nine dogs (three males and six females) with
ADH was 12.3 ± 2.0 years (range: 9 to 15 years), and the
mean body weight of this group was 5.9 ± 2.7 kg (range: 2.1
to 10.0 kg).
No statistically significant differences in body weight
and heart rate among controls, the PDH, and the ADH
groups were found (Table 1). The female to male ratio in
controls, the PDH group, and the ADH group was 0.8,
1.0, and 2.0, respectively. The gender distribution was
not significantly different among groups (P = 0.615).
Systemic blood pressure and conventional
echocardiography
The mean systemic blood pressure was highest in the
ADH group (P = 0.005 versus PDH group and controls,
Table 1). Prevalence of hypertension was also highest in
the ADH group (P = 0.009 versus PDH group and con-
trols, Table 1).
In conventional echocardiographic examinations, most
indices among controls, the PDH, and the ADH groups
were not different, except LVFWd and IVSd, mitral E
Table 1 Baseline characteristics in the control,
pituitary-dependent hyperadrenocorticism (PDH), and
adrenal-dependent hyperadrenocorticism (ADH) groups
Variables Control (n = 9) PDH (n = 10) ADH (n = 9)
Age (y/o) 10.5 ± 2.8 12.5 ± 2.0 12.3 ± 2.0
Body weight (kg) 6.2 ± 2.7 4.5 ± 1.4 5.9 ± 2.7
Female to male 0.8 1 2
Heart rate (bpm) 128.9 ± 23.4 124.6 ± 16.8 129.3 ± 13.7
Blood pressure
(mmHg)




LVEDD (mm) 24.9 ± 3.8 23.6 ± 7.0 21.0 ± 4.8
LVESD (mm) 14.1 ± 2.8 12.9 ± 3.8 12.3 ± 3.1
LVFWd (mm) 4.9 ± 1.1 6.3 ± 1.0† 6.4 ± 1.0†




LA/Ao ratio 1.4 ± 0.1 1.5 ± 0.2 1.4 ± 0.2
EF (%) 75.4 ± 9.5 79.5 ± 5.6 75.0 ± 6.1
FS (%) 43.0 ± 8.0 46.1 ± 5.3 41.3 ± 5.1
Mitral peak E
wave (m/s)
0.82 ± 0.33 0.63 ± 0.13 0.52 ± 0.20†
Mitral E/A ratio 1.07 ± 0.35 0.94 ± 0.29 0.75 ± 0.38
Tricuspid peak E
wave (m/s)
0.50 ± 0.16 0.41 ± 0.10 0.46 ± 0.23
Tricuspid E/A ratio 0.97 ± 0.31 0.94 ± 0.23 0.86 ± 0.43
IVRT (mm) 47.9 ± 8.7 57.4 ± 13.7 64.2 ± 20.3‡†
E/IVRT 1.51 ± 0.34 0.92 ± 0.30† 0.89 ± 0.42†
Indices are presented as mean ± SD.
E/A ratio, early diastolic velocity/late diastolic velocity ratio; EF, ejection
fraction; FS, fractional shortening; IVRT, isovolumetric relaxation time; IVSd,
thickness of interventricular septum at end-diastole; LA/Ao, left atrial/aortic
root ratio; LVEDD, left ventricular dimension at end-diastole; LVESD, left
ventricular dimension at end-systole; LVFWd, thickness of left ventricular free
wall at end-diastole, LVH, left ventricular hypertrophy.
†P < 0.05 relative to controls; ‡P < 0.05 relative to PDH. Table 2 Global strains and strain rates derived from
two-dimensional speckle-tracking echocardiography in
the control, pituitary-dependent hyperadrenocorticism
(PDH), and adrenal-dependent hyperadrenocorticism
(ADH) groups
Variables Control (n = 9) PDH (n = 10) ADH (n = 9)
Global LSRS (s
−1) −1.66 ± 0.42 −1.19 ± 0.54† −1.11 ± 0.20†
Global LSRE (s
−1) 1.29 ± 0.36 0.90 ± 0.51† 0.80 ± 0.36†
Global LSRA (s
−1) 0.95 ± 0.41 0.54 ± 0.25† 0.62 ± 0.40†
Global CSRS (s
−1) −2.21 ± 0.97 −1.37 ± 0.48† −1.07 ± 0.44‡†
Global CSRE (s
−1) 1.52 ± 0.71 0.82 ± 0.46† 0.72 ± 0.23‡†
Global CSRA (s
−1) 0.82 ± 0.35 0.73 ± 0.42 0.60 ± 0.30
Global LS (%) −16.11 ± 3.73 −11.29 ± 5.67† −9.87 ± 1.97†
Global CS (%) −20.39 ± 6.61 −10.22 ± 5.67† −8.68 ± 4.32‡†
A: late diastole; CS: circumferential strain; CSR: circumferential strain rate;
E: early diastole; LS: longitudinal strain; LSR: longitudinal strain rate;
S: peak systole.
†P < 0.05 relative to controls; ‡P < 0.05 relative to PDH.
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were greatest in the ADH group, followed by the PDH
group and controls (P = 0.014 and P = 0.001, respectively,
Table 1). LVH was diagnosed in 56% (5/9) of dogs with
ADH and 40% (4/10) of dogs with PDH (P = 0.656). Five
dogs (ADH, n = 3; PDH, n = 2) were characterized with
symmetric LVH, four dogs (ADH, n = 2; PDH, n = 2)
were characterized with focal and asymmetric LVH.
IVRT was highest in ADH, followed by PDH and con-
trols (P = 0.008, Table 1). Mitral E wave and E/IVRT was
significantly higher in controls, followed by PDH and
ADH (P = 0.036 and P = 0.001, respectively, Table 1). Nei-
ther LVFWd nor IVSd was correlated with systemic blood
pressure (r2 = 0.05, P = 0.238 and r2 = 0.09, P = 0.113, re-
spectively). Neither LVFWd nor IVSd was correlated with
body weight (r2 = 0.05, P = 0.238 and r2 = 0.02, P = 0.482,respectively). Systemic blood pressure was negatively cor-
related with E/IVRT (r2 = −0.19, P = 0.019).
No significant differences in systemic blood pressure,
FS, or EF were found between dogs with LVH (n = 9) and
controls (n = 10; P = 0.125, P = 0.625, and P = 0.843, re-
spectively). No significant differences in systemic blood
pressure was found between HAC dogs with LVH (n = 9)
and without LVH (n = 10; P = 0.935). Significant decreases
in mitral E/A ratio and significant increases in IVRT were
also found in LVH dogs compared to controls (P = 0.041
and P = 0.032, respectively).
Left ventricular strain and strain rate
Almost all variables derived from the segmental and glo-
bal strain/strain rate in longitudinal and circumferential
dynamics followed the same pattern: highest in the con-
trols, followed by the PDH group, then the ADH group
(Tables 2, 3, 4 and 5). Seven of eight global 2D-STE vari-
ables, namely global LSRS, LSRE, LSRA, LS, CSRS, CSRE,
and CS, were significantly different among the ADH,
PDH, and control groups (P = 0.020, P = 0.047, P = 0.049,
P = 0.010, P = 0.004, P = 0.004 and P < 0.001, respectively,
Table 2, Figure 3). Results of the segmental STE derived
from control and the HAC groups are provided in
Tables 3, 4 and 5.
Systemic blood pressure was negatively correlated with
global CRSE (r
2 = −0.16, P = 0.036). No correlation be-
tween age, body weight, and 2D-STE indices were found.
The IVSd was negatively correlated with global LSRS
(r2 = −0.16, P = 0.033), global LSRE (r
2 = −0.14, P = 0.048),
global LS (r2 = −0.28, P = 0.004), global CSRS (r
2 = −0.15,
P = 0.004) and global CS (r2 = −0.25, P = 0.007). The
LVFWd was negatively correlated with global LSRS (r
2 =
−0.15, P = 0.043), global LS (r2 = −0.25, P = 0.007) and
global CS (r2 = −0.16, P = 0.031). The E/IVRT was
Table 3 Indices of left ventricle longitudinal strain rates
(LRS) derived from two-dimensional speckle-tracking
echocardiography in the control, pituitary-dependent






Basal septal Control −1.64 ± 0.43 1.44 ± 0.40 0.91 ± 0.37
PDH −1.29 ± 0.57 1.05 ± 0.50 0.67 ± 0.32
ADH −1.38 ± 0.37 1.05 ± 0.27 0.90 ± 0.61
Mid septal Control −1.72 ± 0.34 1.08 ± 0.42 1.01 ± 0.26
PDH −1.39 ± 0.72 0.97 ± 0.56 0.78 ± 0.26
ADH −1.40 ± 0.20 0.98 ± 0.41 0.83 ± 0.61
Apical septal Control −1.66 ± 0.82 0.90 ± 0.54 0.98 ± 0.46
PDH −1.53 ± 1.04 1.14 ± 0.83 0.81 ± 0.51
ADH −1.39 ± 0.61 0.91 ± 0.33 0.81 ± 0.86
Apical lateral Control −1.56 ± 0.77 1.07 ± 0.58 0.75 ± 0.47
PDH −1.25 ± 0.66 1.02 ± 0.71 0.65 ± 0.42
ADH −1.00 ± 0.57 0.70 ± 0.35 0.55 ± 0.52
Mid lateral Control −1.69 ± 0.76 1.45 ± 0.76 0.75 ± 0.40
PDH −1.22 ± 0.60 1.04 ± 0.50 0.59 ± 0.36
ADH −0.97 ± 0.38† 0.75 ± 0.49 0.59 ± 0.29
Basal lateral Control −1.87 ± 1.01 1.71 ± 1.14 0.84 ± 0.55
PDH −1.52 ± 0.80† 1.17 ± 0.60 0.72 ± 0.37
ADH −1.13 ± 0.28‡† 1.04 ± 0.66 0.68 ± 0.32
A: late diastole; E: early diastole; S: peak systole.
†P < 0.05 relative to controls; ‡P < 0.05 relative to PDH.
Table 4 Indices of left ventricle circumferential strain
rates (CRS) derived from two-dimensional speckle-
tracking echocardiography in the age-matched control,
pituitary-dependent hyperadrenocorticism (PDH), and





Mid antsep Control −2.04 ± 0.48 1.37 ± 0.54 0.78 ± 0.27
PDH −1.01 ± 0.50† 0.63 ± 0.48† 0.71 ± 0.49
ADH −1.35 ± 0.86† 0.91 ± 0.41‡† 0.67 ± 0.36
Mid ant Control −2.09 ± 0.78 1.28 ± 0.49 0.83 ± 0.25
PDH −1.31 ± 0.54 0.64 ± 0.34† 0.88 ± 0.52
ADH −1.58 ± 0.89 0.92 ± 0.55‡† 0.93 ± 0.50
Mid lat Control −2.26 ± 0.78 1.61 ± 0.62 0.83 ± 0.30
PDH −1.52 ± 0.67 1.21 ± 0.52 0.85 ± 0.56
ADH −1.43 ± 0.57† 0.88 ± 0.37† 0.89 ± 0.46
Mid post Control −2.58 ± 0.83 1.83 ± 0.65 1.03 ± 0.58
PDH −1.67 ± 0.66† 1.48 ± 0.78 0.78 ± 0.67
ADH −1.25 ± 0.57‡† 0.89 ± 0.45† 0.75 ± 0.43
Mid inf Control −2.39 ± 0.88 1.85 ± 0.52 1.02 ± 0.46
PDH −1.70 ± 0.68 1.06 ± 0.42 0.92 ± 0.49
ADH −1.01 ± 0.49† 0.75 ± 0.45† 0.59 ± 0.38
Mid sep Control −2.06 ± 0.56 1.59 ± 0.52 0.77 ± 0.27
PDH −1.34 ± 0.72† 0.90 ± 0.42† 0.78 ± 0.50
ADH −1.05 ± 0.52‡† 0.92 ± 0.27‡† 0.48 ± 0.37
A: late diastole; Ant: anterior left ventricular wall; Antsep: anterior septal wall;
E: early diastole; Inf: inferior left ventricular wall; Lat: lateral left ventricular wall;
Mid: middle; Post: posterior left ventricular wall; S: peak systole; Sep:
ventricular septum.
†P < 0.05 relative to controls; ‡P < 0.05 relative to PDH.
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2 = −0.27, P =
0.005), global CSRE (r
2 = −0.32, P = 0.002) and global CS
(r2 = −0.29, P = 0.002).
Seven of eight global 2D-STE variables, namely LSRS,
LSRE, LS, global CSRS, CSRE, and CS, were significantly
decreased in dogs with LVH compared to controls (P =
0.004, P = 0.009, P = 0.002, P = 0.014, P = 0.021 and P =
0.001, respectively); however, these differences between
dogs with LVH (n = 9) and without LVH (n = 10) in the
HAC group did not reach statistical significance.Multiple regression analyses
In the multiple regression analyses, global LS, global LSRS,
and LSRE all decreased linearly with IVSd and were af-
fected by gender (adjusted r2 = 0.531, P < 0.003; adjusted
r2 = 0.408, P = 0.001 and adjusted r2 = 0.214, P = 0.019, re-
spectively), IVSd had the highest r2 in the final model.
Global CS decreased linearly with IVSd (adjusted r2 =
0.223, P = 0.007). Global CSRS decreased linearly with
IVSd and increased linearly with heart rate (adjusted r2 =
0.270, P = 0.008), IVSd had the highest r2 in the final
model. Global CSRE increased linearly with heart rate and
decreased linearly with systemic blood pressure (adjustedr2 = 0.328, P = 0.003), systemic blood pressure had the
highest r2 in the final model.
The intra-observer coefficients of variations (CV) of the
echocardiographic examinations
CV (%) of 2D-STE variables were all less than 20%
(Table 6).
Discussion
Chronic excessive cortisol concentrations might cause
hypertension. Subsequent left ventricular remodeling,
hypertrophy, and altered diastolic function are the most
important risk factors of cardiovascular mortality in hu-
man patients with HAC [19]. Sixty-eight to eighty-five
per cents of human HAC patients developed hyperten-
sion [20,21]. Likewise, systemic hypertension occurs in
47 to 86% of HAC cases in dogs [9,22-24]. In this study,
the prevalence of hypertension in dogs with HAC was
32%. This prevalence of hypertension was low compared
to the other studies, but was consistent with the result
reported in our previous study [10] and was significantly
higher than that of age-matched control dogs. This finding
Table 5 Indices of longitudinal (LS) and circumferential
strains (CS) of left ventricle derived from two-dimensional
speckle-tracking echocardiography in the age-matched
control, pituitary-dependent hyperadrenocorticism (PDH),
and adrenal-dependent hyperadrenocorticism (ADH)
groups
Variables Peak LS (%) Variables Peak CS (%)
Basal septal Mid antsep
Control −16.79 ± 3.97 Control −17.87 ± 4.27
PDH −12.80 ± 5.67 PDH −7.86 ± 4.66†
ADH −11.44 ± 3.60 ADH −10.16 ± 6.92‡†
Mid septal Mid ant
Control −16.99 ± 4.45 Control −18.31 ± 4.06
PDH −13.73 ± 7.21 PDH −9.38 ± 5.90†
ADH −12.58 ± 1.71 ADH −11.66 ± 8.16‡†
Apical septal Mid lat
Control −15.13 ± 6.64 Control 20.21 ± 5.94
PDH −14.89 ± 10.34 PDH 10.51 ± 6.44†
ADH −12.27 ± 4.68 ADH 10.24 ± 5.44‡†
Apical lateral Mid post
Control −14.51 ± 5.47 Control 21.48 ± 7.48
PDH −12.64 ± 8.53 PDH 12.61 ± 7.07†
ADH −8.52 ± 4.85 ADH 8.80 ± 3.95‡†
Mid lateral Mid inf
Control −16.32 ± 9.30 Control 21.16 ± 7.20
PDH −9.80 ± 5.51 PDH 13.03 ± 6.66†
ADH −8.19 ± 4.53† ADH 7.44 ± 3.82‡†
Basal lateral Mid sep
Control −18.46 ± 3.93 Control 18.23 ± 5.25
PDH −10.51 ± 6.16† PDH 10.16 ± 5.42†
ADH −9.84 ± 4.64‡† ADH 7.56 ± 3.58‡†
A: late diastole; Ant: anterior left ventricular wall; Antsep: anterior septal wall;
E: early diastole; Inf: inferior left ventricular wall; Lat: lateral left ventricular wall;
Mid: middle; Post: posterior left ventricular wall; S: peak systole; Sep:
ventricular septum.
†P < 0.05 relative to controls; ‡P < 0.05 relative to PDH.
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ing hypertension. In this study, the condition of HAC was
recently diagnosed. Systemic blood pressure was mea-
sured at the time of the initial diagnosis. A higher preva-
lence of hypertension may be observed at later stages of
the condition.
Cardiac hypertrophy secondary to hypertension and
chronic exposure to excess circulating cortisol may also
contribute directly to left ventricular concentric remodel-
ing in human patients with HAC. Subsequently, functional
abnormality, such as diastolic dysfunction (reduced E/A ra-
tio and/or E velocity) has also been reported in human pa-
tients with HAC [25,26]. In this study, the left ventricular
wall thickness, IVSd, and LVFWd were significantlyincreased in the ADH and PDH groups compared with the
age-matched control group. Significant decreases in mitral
E wave and increases in IVRT were also found in the ADH
and PDH groups compared to the controls. These findings
indicated that dogs with HAC are prone to present with
LVH, impaired LV relaxation and diastolic dysfunction. In
our study, LVH was diagnosed in 47.3% of dogs with HAC.
Based upon the result of this study, LVH was more preva-
lent in small breed dogs with HAC compared to controls.
Although chronic degenerative valvular disease is the most
common acquired cardiac disease in small breeds of dogs
[27], LVH should be a differential diagnosis in small breed
dogs with HAC.
Development of LVH is generally believed to be asso-
ciated with concomitant hypertension in HAC. However
in this study, the wall thickness of the left ventricle was
not correlated with systemic blood pressure. Significant
differences in systemic blood pressure were not found
between dogs with LVH and controls, or between HAC
dogs with LVH and HAC dogs without LVH. No associ-
ation between hypertension and development of LVH
was identified in this study. The mechanism of develop-
ment of LVH in dogs with HAC could not be clarified in
this study.
In 2D-STE analysis, global peak systolic and early dia-
stolic strain rate, as well as global strain in longitudinal
and circumferential dynamics exhibited a consistent
pattern: profound decreases in the ADH and the PDH
groups compared to controls, i.e. significant decreases in
systolic and diastolic functions were observed in the
ADH and PDH groups when compared to controls. Left
ventricular systolic and diastolic dysfunction was also re-
ported in human patients with HAC [5,28]. Diastolic
dysfunction is associated with LVH, whereas systolic dys-
function is associated with LVH and myocardial fibrosis
[5,28]. Upon remission of HAC, left ventricular parame-
ters ameliorate considerably, but does not fully restored
after remission [4].
In this study, 2D-STE revealed alterations in left ven-
tricular mechanics despite a preserved systolic function
detected by conventional echocardiography in dogs with
HAC. The indices of left ventricular systolic function de-
rived from conventional echocardiography, such as FS,
EF, LVEDD and LVESD, were not significantly different
between the HAC group and controls. FS and EF did
not reach significant difference between dogs with LVH
and the control. However decreased systolic function
was revealed using 2D-STE. Decreased systolic function
was most prominent in dogs with LVH associated with
ADH, with decreasing prominence observed in the PDH
group and finally in controls. This finding suggests that
dogs with HAC may have subclinical systolic dysfunc-
tion that may remain undetected using conventional
echocardiographic examination. Similar findings are
Figure 3 Dot-plots of (A) global peak longitudinal strain, (B) global longitudinal strain rate in peak systole, (C) global circumferential
strain in early diastole, (D) global peak circumferential strain, (E) global circumferential strain rate in peak systole and (F)
circumferential strain rate in early diastole derived from two-dimensional speckle-tracking echocardiography in age-matched healthy
controls and dogs affected with pituitary-dependent hyperadrenocorticism (PDH) and adrenal-dependent hyperadrenocorticism (ADH).
†P < 0.05 relative to controls; ‡P < 0.05 relative to PDH.
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hypertrophic cardiomyopathy: subclinical left ventricu-
lar systolic dysfunction is indicated using STE, although
the assessment of FS and EF is usually normal or super-
normal [25,29].Table 6 Within-day intra-observer variability of global
strain (%) and strain rate (1/second) in longitudinal and
circumferential dynamics from six dogs
Within-Day CV% Within-Day SD
LS (%) 13.3 1.25
LSRS (1/s) 10.6 0.12
LSRE (1/s) 11.6 0.10
LSRA (1/s) 16.3 0.09
CS (%) 6.7 1.25
CSRS (1/s) 11.7 0.20
CSRE (1/s) 14.3 0.22
CSRA (1/s) 15.1 0.09
A: late diastole; CS: circumferential strain; CSR: circumferential strain rate; CV,
coefficient of variation; E: early diastole; LS: longitudinal strain; LSR:
longitudinal strain rate; S: peak systole; SD: standard deviation.Global LS, global LSRS, global LSRE, global CS, and
CSRS decreased while IVSd increased, suggesting that de-
creased magnitude and rate of myocardial deformation is
followed by increased LVH. Based on these findings, in-
creased IVSd could be used as predictor of subclinical LV
dysfunction in small breed dogs with HAC. In addition,
global CSRE decreased linearly with increased systemic
blood pressure. Based on this finding, increased systemic
blood pressure could be used as predictor of subclinical
LV diastolic dysfunction in small breed dogs with HAC.
E/IVRT is an index to predict for left ventricular filling
pressure, and increases when LV filling pressure is in-
creased in dogs with congestive heart failure character-
ized by volume overload [30]. In this study, decreased E/
IVRT was found in dogs with HAC. This finding sug-
gested that dogs with HAC might have decreased left
ventricular filling pressure compared to the controls. This
phenomenon might be caused by the decreased volume
load of body fluid associated with the diuretic effect of ele-
vated cortisol concentration in dogs with HAC.
Longitudinal deformation was affected by gender in this
study. Although dogs with HAC are more commonly
Chen et al. Acta Veterinaria Scandinavica  (2014) 56:88 Page 9 of 10female, no gender predilection has been reported. In this
study, 57% of the dogs with HAC were females, a rate
similar to that previously reported [10]; however, the effect
of gender on STE has not been previously reported and
the precise effect of gender on longitudinal deformation
has been unclear.
In this study, the differences of longitudinal 2D-STE
variables among groups were prominent when the ana-
lyses were based upon averaged global deformation com-
paring to the analyses across six myocardial regions.
This might be due the definition of segments. The defin-
ition of segment and post-processing software was based
on human nomenclature or anatomy, and it may not be
necessarily applied to the dogs [31]. Averaged global de-
formation might reasonably reflect the differences ob-
served among groups over the individual segments.
Limitations of this study include low number of dogs.
The dexamethasone suppression test and ACTH con-
centrations were not applied to make a differential diag-
nosis of ADH and PDH. HAC of iatrogenic origin was
predominant in the area where the authors practice. The
differential diagnosis of ADH and PDH was based on
the results of the ACTH stimulation test and ultrasono-
graphic images of adrenal glands. Many HAC cases in
which bilaterally and irregularly enlarged/round adrenals
were presented were excluded from the study. No corre-
sponding aldosterone concentrations were included in
this study.
Competing interests
The authors declare that they have no competing interests.
Authors’ contributions
HYC participated in the design of the study and performed measurements of
systemic blood pressure, conventional echocardiography, and 2D-STE,
drafted the manuscript, and performed the statistical analysis. YHL carried
out the recruitment of cases of hyperadrenocorticism. HPH participated
in the design of the study, carried out the recruitment of cases of
hyperadrenocorticism and prepared the final draft of the manuscript. All
authors read and approved the final manuscript.
Acknowledgements
The authors thank the Consulting Center for Statistics and Bioinformatics,
College of Bio-Resources and Agriculture, National Taiwan University, for
assistance with the statistical analyses.
Author details
1Institute of Veterinary Clinical Science, Veterinary School, National Taiwan
University, No. 1, Section 4, Roosevelt Road, Taipei 106, Taiwan. 2Azu Clinic
for Animals, No. 92, Section 1, Kin-Shan South Road, Taipei 100, Taiwan.
Received: 17 November 2013 Accepted: 10 December 2014
References
1. Ainscough JF, Drinkhill MJ, Sedo A, Turner NA, Brooke DA, Balmforth AJ,
Ball SG: Angiotensin II type-1 receptor activation in the adult heart
causes blood pressure-independent hypertrophy and cardiac
dysfunction. Cardiovasc Res 2009, 81:592–600.
2. Connell JM, MacKenzie SM, Freel EM, Fraser R, Davies E: A lifetime of
aldosterone excess: long-term consequences of altered regulation ofaldosterone production for cardiovascular function. Endocr Rev 2008,
29:133–154.
3. Brilla CG, Weber KT: Mineralocorticoid excess, dietary sodium, and
myocardial fibrosis. J Lab Clin Med 1992, 120:893–901.
4. Toja PM, Branzi G, Ciambellotti F, Radaelli P, De Martin M, Lonati LM, Scacchi
M, Parati G, Cavagnini F, Giraldi FP: Clinical relevance of cardiac structure
and function abnormalities in patients with Cushing’s syndrome before
and after cure. Clin Endocrinol (Oxf ) 2012, 76:332–338.
5. Yiu KH, Marsan NA, Delgado V, Biermasz NR, Holman ER, Smit JW, Feelders
RA, Bax JJ, Pereira AM: Increased myocardial fibrosis and left ventricular
dysfunction in Cushing’s syndrome. Eur J Endocrinol 2012, 166:27–34.
6. Lindholm J, Juul S, Jørgensen JO, Astrup J, Bjerre P, Feldt-Rasmussen U,
Hagen C, Jørgensen J, Kosteljanetz M, Kristensen L, Laurberg P, Schmidt K,
Weeke J: Incidence and late prognosis of cushing’s syndrome: a
population-based study. J Clin Endocrinol Metab 2001, 86:117–123.
7. Colao A, Pivonello R, Spiezia S, Faggiano A, Ferone D, Filippella M, Marzullo P,
Cerbone G, Siciliani M, Lombardi G: Persistence of increased cardiovascular
risk in patients with Cushing’s disease after five years of successful cure.
J Clin Endocrinol Metab 1999, 84:2664–2672.
8. Whitworth JA, Mangos GJ, Kelly JJ: Cushing, cortisol, and cardiovascular
disease. Hypertension 2000, 36:912–916.
9. Ortega TM, Feldman EC, Nelson RW, Willits N, Cowgill LD: Systemic arterial
blood pressure and urine protein/creatinine ratio in dogs with
hyperadrenocorticism. J Am Vet Med Assoc 1996, 209:1724–1729.
10. Lien YH, Hsiang TY, Huang HP: Associations among systemic blood pressure,
microalbuminuria and albuminuria in dogs affected with pituitary- and
adrenal-dependent hyperadrenocorticism. Acta Vet Scand 2010, 52:61.
11. Liu SK, Roberts WC, Maron BJ: Comparison of morphologic findings in
spontaneously occurring hypertrophic cardiomyopathy in humans, cats
and dogs. Am J Cardiol 1993, 72:944–951.
12. Lien Y-H, Huang H-P: Use of ketoconazole to treat dogs with pituitary-
dependent hyperadrenocorticism: 48 cases (1994–2007). J Am Vet Med
Assoc 2008, 233:1896–1901.
13. Barthez PY, Nyland TG, Feldman EC: Ultrasonographic evaluation of the
adrenal glands in dogs. J Am Vet Med Assoc 1995, 207:1180–1183.
14. Hoerauf A, Reusch C: Ultrasonographic characteristics of both adrenal
glands in 15 dogs with functional adrenocortical tumors. J Am Anim Hosp
Assoc 1999, 35:193–199.
15. Brown S, Atkins C, Bagley R, Carr A, Cowgill L, Davidson M, Egner B, Elliott J,
Henik R, Labato M, Littman M, Polzin D, Ross L, Snyder P, Stepien R: Guidelines
for the identification, evaluation, and management of systemic
hypertension in dogs and cats. J Vet Intern Med 2007, 21:542–558.
16. Boon JA: Appehdix 2. Canine M Mode reference range. In Veterinary
Echocardiography. 2nd edition. Wiley-Blackwell, 2011: 538–539.
17. Chetboul V, Serres F, Gouni V, Tissier R, Pouchelon JL: Radial strain and
strain rate by two-dimensional speckle tracking echocardiography and the
tissue velocity based technique in the dog. J Vet Cardiol 2007, 9:69–81.
18. Wess G, Keller LJM, Klausnitzer M, Killich M, Hartmann K: Comparison of
longitudinal myocardial tissue velocity, strain, and strain rate measured
by two-dimensional speckle tracking and by color tissue Doppler
imaging in healthy dogs. J Vet Cardiol 2011, 13:31–43.
19. Arnaldi G: Diagnosis and complications of cushing’s syndrome: a
consensus statement. J Clin Endocrinol Metab 2003, 88:5593–5602.
20. Mancini T, Kola B, Mantero F, Boscaro M, Arnaldi G: High cardiovascular risk
in patients with Cushing’s syndrome according to 1999 WHO/ISH
guidelines. Clin Endocrinol (Oxf ) 2004, 61:768–777.
21. Boscaro M, Barzon L, Fallo F, Sonino N: Cushing’s syndrome. Lancet 2001,
357:783–791.
22. Novellas R, de Gopegui RR, Espada Y: Determination of renal vascular
resistance in dogs with diabetes mellitus and hyperadrenocorticism.
Vet Rec 2008, 163:592–596.
23. Goy-Thollot I, Péchereau D, Kéroack S, Dezempte JC, Bonnet JM:
Investigation of the role of aldosterone in hypertension associated with
spontaneous pituitary-dependent hyperadrenocorticism in dogs.
J Small Anim Pract 2002, 43:489–492.
24. Hurley KJ, Vaden SL: Evaluation of urine protein content in dogs with
pituitary-dependent hyperadrenocorticism. J Am Vet Med Assoc 1998,
212:369–373.
25. Muiesan ML, Lupia M, Salvetti M, Grigoletto C, Sonino N, Boscaro M, Rosei EA,
Mantero F, Fallo F: Left ventricular structural and functional characteristics in
Cushing’s syndrome. J Am Coll Cardiol 2003, 41:2275–2279.
Chen et al. Acta Veterinaria Scandinavica  (2014) 56:88 Page 10 of 1026. Bayram NA, Ersoy R, Aydin C, Gul K, Keles T, Topaloglu O, Durmaz T, Bozkurt E,
Cakir B: Assessment of left ventricular functions by tissue Doppler
echocardiography in patients with Cushing’s disease. J Endocrinol Invest 2009,
32:248–252.
27. Atkins C, Bonagura J, Ettinger S, Fox P, Gordon S, Haggstrom J, Hamlin R,
Keene B, Luis-Fuentes V, Stepien R: Guidelines for the diagnosis and
treatment of canine chronic valvular heart disease. J Vet Intern Med 2009,
23:1142–1150.
28. Muiesan ML, Lupia M, Salvetti M, Grigoletto C, Sonino N, Boscaro M, Rosei EA,
Mantero F, Fallo F: Left ventricular structural and functional characteristics in
Cushing’s syndrome. J Am Coll Cardiol 2003, 41:2275–2279.
29. Pereira AM, Delgado V, Romijn JA, Smit JW, Bax JJ, Feelders RA:
Cardiac dysfunction is reversed upon successful treatment of Cushing’s
syndrome. Eur J Endocrinol 2010, 162:331–340.
30. Schober KE, Stern JA, DaCunha DNQT, Pedraza-Toscano AM, Shemanski D,
Hamlin LR: Estimation of left ventricular filling pressure by doppler
echocardiography in dogs with pacing-induced heart failure. J Vet Intern
Med 2008, 22:578–585.
31. Smith DN, Bonagura JD, Culwell NM, Schober KE: Left ventricular function
quantified by myocardial strain imaging in small-breed dogs with
chronic mitral regurgitation. J Vet Cardiol 2012, 14:231–242.Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
